
VentureSouth
Description
VentureSouth is a prominent early-stage venture firm and the largest angel investment group in the Southeastern United States. Based in Greenville, South Carolina, with additional offices in Charlotte and Charleston, it operates a robust network of over 400 angel investors. The firm primarily focuses on investing in promising companies located within the Southeast, leveraging its extensive regional presence and deep understanding of the local entrepreneurial ecosystem.
The firm targets early-stage companies that are typically raising between $500,000 and $5 million in their funding rounds. VentureSouth seeks out businesses with strong management teams, significant addressable markets, and defensible technology or business models. A clear path to exit is also a crucial criterion for their investment decisions, indicating a focus on scalable ventures with potential for substantial returns.
VentureSouth's initial investment checks typically range from $250,000 to $1.5 million, reflecting their commitment to providing meaningful early capital. Since its inception in 2008, the firm has demonstrated significant activity, deploying over $75 million across more than 80 companies. This substantial investment has helped their portfolio companies collectively raise over $1.2 billion in subsequent follow-on capital, underscoring VentureSouth's role as a catalyst for growth in the regional startup landscape.
Investor Profile
VentureSouth has backed more than 155 startups, with 0 new investments in the last 12 months alone. The firm has led 26 rounds, about 17% of its total and boasts 13 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Convertible Note, Seed, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Software, Health Care.
- Typical check size: $250K – $1.5M.
Stage Focus
- Convertible Note (29%)
- Seed (27%)
- Series A (25%)
- Series B (6%)
- Series Unknown (5%)
- Series C (3%)
- Debt Financing (1%)
- Series F (1%)
- Series E (1%)
- Grant (1%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Software
- Health Care
- Medical
- Health Diagnostics
- Life Science
- Saas
- Internet
- Manufacturing
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.